US: AKBLF - ALK-Abelló A/S

छह महीने के लिए लाभप्रदता: +46.12%

पदोन्नति कार्यक्रम ALK-Abelló A/S

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.

अधिक जानकारी
It also provides consumer healthcare solution, which include Digital eco-system, a platform which connect and engages with allergy sufferers in the disease journey through tools and e-commerce offerings that supports, guidance and relief, and smoothing the path to allergy immunotherapy treatment. In addition, the company offers diagnostic allergy solutions through testing by skin prick test or blood test; and emergency treatment, such as intra-muscular injection of adrenaline for the treatment of acute life-threatening allergic reactions, including Anaphylaxis. The company has a collaboration with Torii Pharmaceutical Co., Ltd. to develop, market and distribute allergy immunotherapy tablet for the treatment of grass pollen allergy. ALK-Abelló A/S was founded in 1923 and is headquartered in Horsholm, Denmark.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета dkk
Сайт https://www.alk.net
Цена ао 27.03
प्रति दिन मूल्य परिवर्तन: 0% (27.0328)
प्रति सप्ताह मूल्य परिवर्तन: +9.89% (24.6)
प्रति माह मूल्य परिवर्तन: +24.69% (21.68)
3 महीने में कीमत में बदलाव: +33.17% (20.3)
छह महीने में कीमत में बदलाव: +46.12% (18.5)
प्रति वर्ष मूल्य परिवर्तन: +137.13% (11.4)
3 वर्षों में मूल्य परिवर्तन: -94.45% (487)
5 वर्षों में मूल्य परिवर्तन: -87.8% (221.5)
10 वर्षों में मूल्य परिवर्तन: 0% (27.0328)
वर्ष की शुरुआत से मूल्य परिवर्तन: +137.13% (11.4)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
कुल: 2.5

क्षमता

नाम अर्थ श्रेणी
ROA, % 0 0
ROE, % 0 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 1 10
कुल: 1.61

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA 0 10
कुल: 10

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 47.34 6
लाभप्रदता Ebitda, % 268.55 10
लाभप्रदता EPS, % -833.33 0
कुल: 3.2
अधिक जानकारी

पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Claus Steensen Solje Executive VP, CFO & Member of Management Board 1972 (52 वर्ष)
Mr. Søren Daniel Niegel Executive VP of Commercial Operations & Member of Management Board 1971 (53 वर्ष)
Dr. Henriette Mersebach Executive VP Research & Development & Member of Management Board 1971 (53 वर्ष)
Ms. Katja Barnkob Thalund Project Director of Global CMC Development & Employee-elected Director 1969 (55 साल)
Ms. Lise Lund Maerkedahl Project Director of Global Research & Employee-elected Director 1967 (57 साल)
Mr. Peter Halling President & CEO 1977 (47 साल)
Mr. Per Plotnikof VP of Corporate Communications, Investor Relations & Strategic Planning and Head of IR
Prof. Hendrik Kees Kam Nolte M.D., Ph.D. Senior Vice President of Research & Development - North America and International Markets
Mr. Christian G. Houghton Head of Product Supply
Mr. Peter Sejer Andersen Senior Vice President of Global Research & Drug Discovery

पता: Denmark, Horsholm, BOege AllE 6-8 - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.alk.net